Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation —A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation
Discussion: AREST will offer randomized controlled trial data about timeliness and safety of anticoagulation in AIS patients with AF.Clinical Trial Registration:www.ClinicalTrials.gov, identifier NCT02283294.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Atrial Fibrillation | Brain | Clinical Trials | Coumadin | Disability | Hemorrhagic Stroke | Ischemic Stroke | National Institutes of Health (NIH) | Neurology | Stroke | Study | Warfarin